Human Immunodeficiency Virus Type 1 (HIV-1) PhenoSense
Also known as: HIV PHENO
Use
The HIV-1 PhenoSense test is intended for use in patients with viral loads equal to or above 500 copies/mL. It provides antiretroviral susceptibility information for protease inhibitors and reverse transcriptase inhibitors, including both NRTI and NNRTI. The test helps in assessing the resistance pattern of HIV-1 to various antiretroviral drugs, thereby informing treatment decisions.
Special Instructions
The specimen must be separated from cells within 6 hours of collection and frozen immediately. Separate specimens must be submitted if multiple tests are ordered.
Limitations
This test is validated for HIV-1 viral loads equal to or above 500 copies/mL and should only be interpreted for such specimens. It should not be used as the sole criterion for patient management. The test has not been cleared or approved by the FDA.
New York Approved
Methodology
PCR-based
Biomarkers
LOINC Codes
- 11502-2
- 45182-3
- 83327-7
Result Turnaround Time
27-38 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
3 mL
Minimum Volume
3 mL
Container
ARUP standard transport tube
Collection Instructions
Separate from cells within 6 hours of collection. Freeze immediately.
Storage Instructions
CRITICAL FROZEN.
Causes for Rejection
Thawed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 6 hours |
| Refrigerated | 24 hours |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant